STEPHANIE GRAVOIS-RUPE: Open Payments
NPI 1891915468 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 8 payments from 5 companies in 2025. Trend: 2023 $218 · 2024 $203 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 4 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: Azstarys, TRINTELLIX, ARISTADA, AUSTEDO XR, INGREZZA.
Industry payments across LA — which companies pay providers there.
